Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−81.66 M USD
7.16 M USD
20.09 M
About Acutus Medical Inc.
Sector
Industry
CEO
Takeo Mukai
Website
Headquarters
Carlsbad
Founded
2011
FIGI
BBG00W2RQ9Q1
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AFIB is 0.0658 USD — it has increased by 4.45% in the past 24 hours. Watch Acutus Medical Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Acutus Medical Inc. stocks are traded under the ticker AFIB.
AFIB stock has risen by 6.39% compared to the previous week, the month change is a −51.30% fall, over the last year Acutus Medical Inc. has showed a −74.22% decrease.
AFIB reached its all-time high on Sep 2, 2020 with the price of 38.9900 USD, and its all-time low was 0.0251 USD and was reached on Jul 12, 2024. View more price dynamics on AFIB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AFIB stock is 40.35% volatile and has beta coefficient of 0.75. Track Acutus Medical Inc. stock price on the chart and check out the list of the most volatile stocks — is Acutus Medical Inc. there?
Today Acutus Medical Inc. has the market capitalization of 1.97 M, it has decreased by −0.08% over the last week.
Yes, you can track Acutus Medical Inc. financials in yearly and quarterly reports right on TradingView.
Acutus Medical Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
AFIB earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.41 USD resulting in a 92.67% surprise. The estimated earnings for the next quarter are −0.40 USD per share. See more details about Acutus Medical Inc. earnings.
Acutus Medical Inc. revenue for the last quarter amounts to 5.27 M USD, despite the estimated figure of 7.76 M USD. In the next quarter, revenue is expected to reach 8.67 M USD.
AFIB net income for the last quarter is −5.61 M USD, while the quarter before that showed −914.00 K USD of net income which accounts for −513.46% change. Track more Acutus Medical Inc. financial stats to get the full picture.
No, AFIB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 233.00 employees. See our rating of the largest employees — is Acutus Medical Inc. on this list?
Like other stocks, AFIB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acutus Medical Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Acutus Medical Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Acutus Medical Inc. stock shows the sell signal. See more of Acutus Medical Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.